NCT07235111 · RECRUITING

Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases

This study collects genetic, protein, and metabolic data from people with neurodegenerative diseases — including Alzheimer's, Parkinson's, ALS, FTD, and MCI — to look for biological patterns that might one day improve diagnosis or monitoring. It is an observational research study, not a treatment trial. No drug or intervention is being tested. Details on specific methods and enrollment criteria are limited so far.

Eligibility criteria

Inclusion Criteria
• Patients suffering from neurodegenerative diseases
Exclusion Criteria
• Patients not suffering from neurodegenerative diseases

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-11-25

View full record on ClinicalTrials.gov

All APOE4 clinical trials